IFNA17 and cancer: More specifically, the pathways most enriched for the late-replicating genes in cancer included cytokine-cytokine receptor interaction, interferon-α/β (IFN-α/β) signaling, and RIG-1/MDA5-mediated IFN-α/β induction (Fig. 3e and Supplementary Table 1).